aluates Reports

$ 0.0

Automative

Global Cancer Immunotherapy Drug Discovery Outsourcing Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-11V13905

Global Cancer Immunotherapy Drug Discovery Outsourcing Market Research Report 2023

BUY CHAPTERS

Global Cancer Immunotherapy Drug Discovery Outsourcing Market Insights, Forecast to 2030

Code: QYRE-Auto-11V13905

Report

December 2024

Pages:110

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Aquila BioMedical

BPS Bioscience, Inc.

Celentyx Ltd

Crown Bioscience Inc

DiscoveRx Corporation

Explicyte

Genscript Biotech Corporation

HD Biosciences Co.

Horizon Discovery Group plc

ImmunXperts SA

Molecular Imaging, Inc.

Promega Corporation,Personalis, Inc.

STC Biologics

Cancer Immunotherapy Drug Discovery Outsourcing Market Size

The global Cancer Immunotherapy Drug Discovery Outsourcing market is projected to grow from US$ 1119.1 million in 2024 to US$ 2057.2 million by 2030, at a Compound Annual Growth Rate (CAGR) of 10.7% during the forecast period.

Cancer Immunotherapy Drug Discovery Outsourcing Market

Market Analysis and Insights: Global Cancer Immunotherapy Drug Discovery Outsourcing Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Cancer Immunotherapy Drug Discovery Outsourcing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Cancer Immunotherapy Drug Discovery Outsourcing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Cancer Immunotherapy Drug Discovery Outsourcing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cancer Immunotherapy Drug Discovery Outsourcing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Cancer Immunotherapy Drug Discovery Outsourcing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Cancer Immunotherapy Drug Discovery Outsourcing revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Cancer Immunotherapy Drug Discovery Outsourcing Market Report

Report Metric	Details
Report Name	Cancer Immunotherapy Drug Discovery Outsourcing Market
Accounted market size in 2024	US$ 1119.1 million
Forecasted market size in 2030	US$ 2057.2 million
CAGR	10.7
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	By Drug Type By Cancer Type
Segment by Application	Lung Breast Colorectal Melanoma Prostate Head and Neck Ovarian Pancreatic
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Aquila BioMedical, BPS Bioscience, Inc., Celentyx Ltd, Crown Bioscience, Inc., DiscoverX Corporation, Explicyte, Genscript Biotech Corporation, HD Biosciences Co., Horizon Discovery Group PLC, ImmunXperts SA, Molecular Imaging, Inc., Promega Corporation,Personalis, Inc., STC Biologics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Cancer Immunotherapy Drug Discovery Outsourcing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Immunotherapy Drug Discovery Outsourcing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cancer Immunotherapy Drug Discovery Outsourcing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Cancer Immunotherapy Drug Discovery Outsourcing Market growing?

Ans: The Cancer Immunotherapy Drug Discovery Outsourcing Market witnessing a CAGR of 10.7 during the forecast period 2025-2030.

What is the Cancer Immunotherapy Drug Discovery Outsourcing Market size in 2030?

Ans: The Cancer Immunotherapy Drug Discovery Outsourcing Market size in 2030 will be US$ 2057.2 million.

Who are the main players in the Cancer Immunotherapy Drug Discovery Outsourcing Market report?

Ans: The main players in the Cancer Immunotherapy Drug Discovery Outsourcing Market are Aquila BioMedical, BPS Bioscience, Inc., Celentyx Ltd, Crown Bioscience, Inc., DiscoverX Corporation, Explicyte, Genscript Biotech Corporation, HD Biosciences Co., Horizon Discovery Group PLC, ImmunXperts SA, Molecular Imaging, Inc., Promega Corporation,Personalis, Inc., STC Biologics

What are the Application segmentation covered in the Cancer Immunotherapy Drug Discovery Outsourcing Market report?

Ans: The Applications covered in the Cancer Immunotherapy Drug Discovery Outsourcing Market report are Lung, Breast, Colorectal, Melanoma, Prostate, Head and Neck, Ovarian, Pancreatic

What are the Type segmentation covered in the Cancer Immunotherapy Drug Discovery Outsourcing Market report?

Ans: The Types covered in the Cancer Immunotherapy Drug Discovery Outsourcing Market report are By Drug Type, By Cancer Type

Recommended Reports

Cancer Drug Markets

Diagnostic & Therapy

Drug Discovery Outsourcing

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 By Drug Type

1.2.3 By Cancer Type

1.3 Market by Application

1.3.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Lung

1.3.3 Breast

1.3.4 Colorectal

1.3.5 Melanoma

1.3.6 Prostate

1.3.7 Head and Neck

1.3.8 Ovarian

1.3.9 Pancreatic

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Perspective (2019-2030)

2.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Growth Trends by Region

2.2.1 Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Cancer Immunotherapy Drug Discovery Outsourcing Historic Market Size by Region (2019-2024)

2.2.3 Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Region (2025-2030)

2.3 Cancer Immunotherapy Drug Discovery Outsourcing Market Dynamics

2.3.1 Cancer Immunotherapy Drug Discovery Outsourcing Industry Trends

2.3.2 Cancer Immunotherapy Drug Discovery Outsourcing Market Drivers

2.3.3 Cancer Immunotherapy Drug Discovery Outsourcing Market Challenges

2.3.4 Cancer Immunotherapy Drug Discovery Outsourcing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Cancer Immunotherapy Drug Discovery Outsourcing by Players

3.1.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Players (2019-2024)

3.1.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Players (2019-2024)

3.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Cancer Immunotherapy Drug Discovery Outsourcing, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Concentration Ratio

3.4.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cancer Immunotherapy Drug Discovery Outsourcing Revenue in 2023

3.5 Global Key Players of Cancer Immunotherapy Drug Discovery Outsourcing Head office and Area Served

3.6 Global Key Players of Cancer Immunotherapy Drug Discovery Outsourcing, Product and Application

3.7 Global Key Players of Cancer Immunotherapy Drug Discovery Outsourcing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Immunotherapy Drug Discovery Outsourcing Breakdown Data by Type

4.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Historic Market Size by Type (2019-2024)

4.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Type (2025-2030)

5 Cancer Immunotherapy Drug Discovery Outsourcing Breakdown Data by Application

5.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Historic Market Size by Application (2019-2024)

5.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2019-2030)

6.2 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type

6.2.1 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2019-2024)

6.2.2 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2025-2030)

6.2.3 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2019-2030)

6.3 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application

6.3.1 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2019-2024)

6.3.2 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2025-2030)

6.3.3 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2019-2030)

6.4 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country

6.4.1 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2019-2024)

6.4.3 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2019-2030)

7.2 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type

7.2.1 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2019-2024)

7.2.2 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2025-2030)

7.2.3 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2019-2030)

7.3 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application

7.3.1 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2019-2024)

7.3.2 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2025-2030)

7.3.3 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2019-2030)

7.4 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country

7.4.1 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2019-2024)

7.4.3 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2019-2030)

8.2 China Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type

8.2.1 China Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2019-2024)

8.2.2 China Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2025-2030)

8.2.3 China Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2019-2030)

8.3 China Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application

8.3.1 China Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2019-2024)

8.3.2 China Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2025-2030)

8.3.3 China Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2019-2030)

9.2 Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type

9.2.1 Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2019-2024)

9.2.2 Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2025-2030)

9.2.3 Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2019-2030)

9.3 Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application

9.3.1 Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2019-2024)

9.3.2 Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2025-2030)

9.3.3 Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2019-2030)

9.4 Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region

9.4.1 Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region (2019-2024)

9.4.3 Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type

10.2.1 Middle East, Africa, and Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application

10.3.1 Middle East, Africa, and Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country

10.4.1 Middle East, Africa, and Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Aquila BioMedical

11.1.1 Aquila BioMedical Company Details

11.1.2 Aquila BioMedical Business Overview

11.1.3 Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Introduction

11.1.4 Aquila BioMedical Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024)

11.1.5 Aquila BioMedical Recent Developments

11.2 BPS Bioscience, Inc.

11.2.1 BPS Bioscience, Inc. Company Details

11.2.2 BPS Bioscience, Inc. Business Overview

11.2.3 BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Introduction

11.2.4 BPS Bioscience, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024)

11.2.5 BPS Bioscience, Inc. Recent Developments

11.3 Celentyx Ltd

11.3.1 Celentyx Ltd Company Details

11.3.2 Celentyx Ltd Business Overview

11.3.3 Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Introduction

11.3.4 Celentyx Ltd Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024)

11.3.5 Celentyx Ltd Recent Developments

11.4 Crown Bioscience, Inc.

11.4.1 Crown Bioscience, Inc. Company Details

11.4.2 Crown Bioscience, Inc. Business Overview

11.4.3 Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Introduction

11.4.4 Crown Bioscience, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024)

11.4.5 Crown Bioscience, Inc. Recent Developments

11.5 DiscoverX Corporation

11.5.1 DiscoverX Corporation Company Details

11.5.2 DiscoverX Corporation Business Overview

11.5.3 DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Introduction

11.5.4 DiscoverX Corporation Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024)

11.5.5 DiscoverX Corporation Recent Developments

11.6 Explicyte

11.6.1 Explicyte Company Details

11.6.2 Explicyte Business Overview

11.6.3 Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Introduction

11.6.4 Explicyte Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024)

11.6.5 Explicyte Recent Developments

11.7 Genscript Biotech Corporation

11.7.1 Genscript Biotech Corporation Company Details

11.7.2 Genscript Biotech Corporation Business Overview

11.7.3 Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Introduction

11.7.4 Genscript Biotech Corporation Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024)

11.7.5 Genscript Biotech Corporation Recent Developments

11.8 HD Biosciences Co.

11.8.1 HD Biosciences Co. Company Details

11.8.2 HD Biosciences Co. Business Overview

11.8.3 HD Biosciences Co. Cancer Immunotherapy Drug Discovery Outsourcing Introduction

11.8.4 HD Biosciences Co. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024)

11.8.5 HD Biosciences Co. Recent Developments

11.9 Horizon Discovery Group PLC

11.9.1 Horizon Discovery Group PLC Company Details

11.9.2 Horizon Discovery Group PLC Business Overview

11.9.3 Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Introduction

11.9.4 Horizon Discovery Group PLC Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024)

11.9.5 Horizon Discovery Group PLC Recent Developments

11.10 ImmunXperts SA

11.10.1 ImmunXperts SA Company Details

11.10.2 ImmunXperts SA Business Overview

11.10.3 ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Introduction

11.10.4 ImmunXperts SA Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024)

11.10.5 ImmunXperts SA Recent Developments

11.11 Molecular Imaging, Inc.

11.11.1 Molecular Imaging, Inc. Company Details

11.11.2 Molecular Imaging, Inc. Business Overview

11.11.3 Molecular Imaging, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Introduction

11.11.4 Molecular Imaging, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024)

11.11.5 Molecular Imaging, Inc. Recent Developments

11.12 Promega Corporation,Personalis, Inc.

11.12.1 Promega Corporation,Personalis, Inc. Company Details

11.12.2 Promega Corporation,Personalis, Inc. Business Overview

11.12.3 Promega Corporation,Personalis, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Introduction

11.12.4 Promega Corporation,Personalis, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024)

11.12.5 Promega Corporation,Personalis, Inc. Recent Developments

11.13 STC Biologics

11.13.1 STC Biologics Company Details

11.13.2 STC Biologics Business Overview

11.13.3 STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Introduction

11.13.4 STC Biologics Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024)

11.13.5 STC Biologics Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Aquila BioMedical

BPS Bioscience, Inc.

Celentyx Ltd

Crown Bioscience Inc

DiscoveRx Corporation

Explicyte

Genscript Biotech Corporation

HD Biosciences Co.

Horizon Discovery Group plc

ImmunXperts SA

Molecular Imaging, Inc.

Promega Corporation,Personalis, Inc.

STC Biologics

List of Tables

Table 1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Type I

Table 3. Key Players of Type II

Table 4. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 5. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Region (2019-2024)

Table 8. Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Region (2025-2030)

Table 10. Cancer Immunotherapy Drug Discovery Outsourcing Market Trends

Table 11. Cancer Immunotherapy Drug Discovery Outsourcing Market Drivers

Table 12. Cancer Immunotherapy Drug Discovery Outsourcing Market Challenges

Table 13. Cancer Immunotherapy Drug Discovery Outsourcing Market Restraints

Table 14. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Share by Players (2019-2024)

Table 16. Global Top Cancer Immunotherapy Drug Discovery Outsourcing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Immunotherapy Drug Discovery Outsourcing as of 2023)

Table 17. Global Cancer Immunotherapy Drug Discovery Outsourcing Industry Ranking 2022 VS 2023 VS 2024

Table 18. Global 5 Largest Players Market Share by Cancer Immunotherapy Drug Discovery Outsourcing Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Cancer Immunotherapy Drug Discovery Outsourcing, Headquarters and Area Served

Table 20. Global Key Players of Cancer Immunotherapy Drug Discovery Outsourcing, Product and Application

Table 21. Global Key Players of Cancer Immunotherapy Drug Discovery Outsourcing, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Type (2019-2024)

Table 25. Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Type (2025-2030)

Table 27. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Share by Application (2019-2024)

Table 29. Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Share by Application (2025-2030)

Table 31. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2019-2024) & (US$ Million)

Table 32. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2025-2030) & (US$ Million)

Table 33. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2019-2024) & (US$ Million)

Table 34. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2025-2030) & (US$ Million)

Table 35. North America Cancer Immunotherapy Drug Discovery Outsourcing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2019-2024) & (US$ Million)

Table 39. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2025-2030) & (US$ Million)

Table 40. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2019-2024) & (US$ Million)

Table 41. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2025-2030) & (US$ Million)

Table 42. Europe Cancer Immunotherapy Drug Discovery Outsourcing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2019-2024) & (US$ Million)

Table 44. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2025-2030) & (US$ Million)

Table 45. China Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2019-2024) & (US$ Million)

Table 46. China Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2025-2030) & (US$ Million)

Table 47. China Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2019-2024) & (US$ Million)

Table 48. China Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2025-2030) & (US$ Million)

Table 49. Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2019-2024) & (US$ Million)

Table 50. Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2025-2030) & (US$ Million)

Table 51. Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2019-2024) & (US$ Million)

Table 52. Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia Cancer Immunotherapy Drug Discovery Outsourcing Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 54. Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region (2019-2024) & (US$ Million)

Table 55. Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region (2025-2030) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2019-2024) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Cancer Immunotherapy Drug Discovery Outsourcing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 61. Middle East, Africa, and Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2025-2030) & (US$ Million)

Table 63. Aquila BioMedical Company Details

Table 64. Aquila BioMedical Business Overview

Table 65. Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Product

Table 66. Aquila BioMedical Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024) & (US$ Million)

Table 67. Aquila BioMedical Recent Developments

Table 68. BPS Bioscience, Inc. Company Details

Table 69. BPS Bioscience, Inc. Business Overview

Table 70. BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product

Table 71. BPS Bioscience, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024) & (US$ Million)

Table 72. BPS Bioscience, Inc. Recent Developments

Table 73. Celentyx Ltd Company Details

Table 74. Celentyx Ltd Business Overview

Table 75. Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Product

Table 76. Celentyx Ltd Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024) & (US$ Million)

Table 77. Celentyx Ltd Recent Developments

Table 78. Crown Bioscience, Inc. Company Details

Table 79. Crown Bioscience, Inc. Business Overview

Table 80. Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product

Table 81. Crown Bioscience, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024) & (US$ Million)

Table 82. Crown Bioscience, Inc. Recent Developments

Table 83. DiscoverX Corporation Company Details

Table 84. DiscoverX Corporation Business Overview

Table 85. DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Product

Table 86. DiscoverX Corporation Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024) & (US$ Million)

Table 87. DiscoverX Corporation Recent Developments

Table 88. Explicyte Company Details

Table 89. Explicyte Business Overview

Table 90. Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Product

Table 91. Explicyte Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024) & (US$ Million)

Table 92. Explicyte Recent Developments

Table 93. Genscript Biotech Corporation Company Details

Table 94. Genscript Biotech Corporation Business Overview

Table 95. Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Product

Table 96. Genscript Biotech Corporation Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024) & (US$ Million)

Table 97. Genscript Biotech Corporation Recent Developments

Table 98. HD Biosciences Co. Company Details

Table 99. HD Biosciences Co. Business Overview

Table 100. HD Biosciences Co. Cancer Immunotherapy Drug Discovery Outsourcing Product

Table 101. HD Biosciences Co. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024) & (US$ Million)

Table 102. HD Biosciences Co. Recent Developments

Table 103. Horizon Discovery Group PLC Company Details

Table 104. Horizon Discovery Group PLC Business Overview

Table 105. Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Product

Table 106. Horizon Discovery Group PLC Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024) & (US$ Million)

Table 107. Horizon Discovery Group PLC Recent Developments

Table 108. ImmunXperts SA Company Details

Table 109. ImmunXperts SA Business Overview

Table 110. ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Product

Table 111. ImmunXperts SA Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024) & (US$ Million)

Table 112. ImmunXperts SA Recent Developments

Table 113. Molecular Imaging, Inc. Company Details

Table 114. Molecular Imaging, Inc. Business Overview

Table 115. Molecular Imaging, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product

Table 116. Molecular Imaging, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024) & (US$ Million)

Table 117. Molecular Imaging, Inc. Recent Developments

Table 118. Promega Corporation,Personalis, Inc. Company Details

Table 119. Promega Corporation,Personalis, Inc. Business Overview

Table 120. Promega Corporation,Personalis, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product

Table 121. Promega Corporation,Personalis, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024) & (US$ Million)

Table 122. Promega Corporation,Personalis, Inc. Recent Developments

Table 123. STC Biologics Company Details

Table 124. STC Biologics Business Overview

Table 125. STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Product

Table 126. STC Biologics Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024) & (US$ Million)

Table 127. STC Biologics Recent Developments

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type: 2023 VS 2030

Figure 3. Type I Features

Figure 4. Type II Features

Figure 5. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 6. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application: 2023 VS 2030

Figure 7. Lung Case Studies

Figure 8. Breast Case Studies

Figure 9. Colorectal Case Studies

Figure 10. Melanoma Case Studies

Figure 11. Prostate Case Studies

Figure 12. Head and Neck Case Studies

Figure 13. Ovarian Case Studies

Figure 14. Pancreatic Case Studies

Figure 15. Cancer Immunotherapy Drug Discovery Outsourcing Report Years Considered

Figure 16. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 17. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 18. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Region: 2023 VS 2030

Figure 19. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Players in 2023

Figure 20. Global Top Cancer Immunotherapy Drug Discovery Outsourcing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Immunotherapy Drug Discovery Outsourcing as of 2023)

Figure 21. The Top 10 and 5 Players Market Share by Cancer Immunotherapy Drug Discovery Outsourcing Revenue in 2023

Figure 22. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2019-2030)

Figure 24. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2019-2030)

Figure 25. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Country (2019-2030)

Figure 26. United States Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY (2019-2030) & (US$ Million)

Figure 29. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2019-2030)

Figure 30. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2019-2030)

Figure 31. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Country (2019-2030)

Figure 32. Germany Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. France Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. U.K. Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Italy Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Russia Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Nordic Countries Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. China Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY (2019-2030) & (US$ Million)

Figure 39. China Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2019-2030)

Figure 40. China Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2019-2030)

Figure 41. Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY (2019-2030) & (US$ Million)

Figure 42. Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2019-2030)

Figure 43. Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2019-2030)

Figure 44. Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Region (2019-2030)

Figure 45. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. China Taiwan Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. India Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Australia Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Middle East, Africa, and Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY (2019-2030) & (US$ Million)

Figure 52. Middle East, Africa, and Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2019-2030)

Figure 53. Middle East, Africa, and Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2019-2030)

Figure 54. Middle East, Africa, and Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Country (2019-2030)

Figure 55. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Turkey Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Saudi Arabia Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. Israel Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 60. GCC Countries Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 61. Aquila BioMedical Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024)

Figure 62. BPS Bioscience, Inc. Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024)

Figure 63. Celentyx Ltd Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024)

Figure 64. Crown Bioscience, Inc. Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024)

Figure 65. DiscoverX Corporation Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024)

Figure 66. Explicyte Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024)

Figure 67. Genscript Biotech Corporation Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024)

Figure 68. HD Biosciences Co. Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024)

Figure 69. Horizon Discovery Group PLC Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024)

Figure 70. ImmunXperts SA Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024)

Figure 71. Molecular Imaging, Inc. Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024)

Figure 72. Promega Corporation,Personalis, Inc. Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024)

Figure 73. STC Biologics Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024)

Figure 74. Bottom-up and Top-down Approaches for This Report

Figure 75. Data Triangulation

Figure 76. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global PD 1 and PD L1 Immunotherapy Market Insights Forecast to 2030

Global Metastatic Colorectal Cancer Drug Market Insights Forecast to 2030

Global Drug Discovery Assays Market Insights Forecast to 2030

Global Anti PD 1 MAb Market Insights Forecast to 2030

Global Purchasing Outsourcing Market Insights Forecast to 2030

Global Pharmaceutical Contract Development and Manufacturing Market Insights Forecast to 2030

Global Systemic Lupus Erythematosus Treatment Market Insights Forecast to 2030

Global TCR T Therapy Reagent Market Insights Forecast to 2030

Global Strategic Sourcing Software Market Insights Forecast to 2030

Global PD 1 and PD L1 Antibody Market Insights Forecast to 2030

Global CTLA 4 Protein Market Insights Forecast to 2030

Global Osteoporosis Treatment Market Insights Forecast to 2030

Global Finance and Accounting Outsourcing Services Market Insights Forecast to 2030

Global Cryotherapy Market Insights Forecast to 2030

Global Health Care Cloud and Hosting Market Insights Forecast to 2030

Global Finance and Accounting Business Process Outsourcing Service Market Insights Forecast to 2030

Global Photodynamic Therapy Market Insights Forecast to 2030

Global Metabolic Disorder Therapeutics Market Insights Forecast to 2030

Global Nasal Polyps Treatment Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions